[An imported case of falciparum malaria successfully treated with Artemether-Lumefantrine in Japan].
Identifieur interne : 000693 ( PubMed/Checkpoint ); précédent : 000692; suivant : 000694[An imported case of falciparum malaria successfully treated with Artemether-Lumefantrine in Japan].
Auteurs : Azumi Ishizaki ; Yoshiki Kikuchi ; Toshimitsu Hatabu ; Shigeyuki Kano ; Akira Yasuoka ; Shinichi OkaSource :
- Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases [ 0387-5911 ] ; 2003.
Descripteurs français
- KwdFr :
- MESH :
- traitement médicamenteux : Paludisme à Plasmodium falciparum.
- usage thérapeutique : Antipaludiques, Artémisinines, Sesquiterpènes.
- Adulte, Femelle, Ghana, Humains, Voyage.
- Wicri :
- geographic : Ghana.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Antimalarials, Artemisinins, Sesquiterpenes.
- geographic : Ghana.
- drug therapy : Malaria, Falciparum.
- Adult, Female, Humans, Travel.
Abstract
Spread of multi-drug resistant malaria in the endemic areas has made malaria control more difficult. Thus, WHO recommends combination therapy for the treatment of malaria. The aim of combination therapy is to improve efficacy and to reduce the incidence of resistance development to the each component of the combination. Particularly, the combination with artemisinin derivatives shows good outcome in Thailand where high resistance for mefloquine has already been found. We report the first case of falciparum malaria, successfully treated with Artemether-Lumefantrine in Japan. Artemether-Lumefantrine is a newly developed artemisinin-based combination agent for the treatment of uncomplicated multi-drug resistant malaria. This drug has proved highly effective and well tolerated by some clinical trials abroad. This Japanese female case showed a good clinical course without any side effect.
PubMed: 12638260
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:12638260Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[An imported case of falciparum malaria successfully treated with Artemether-Lumefantrine in Japan].</title><author><name sortKey="Ishizaki, Azumi" sort="Ishizaki, Azumi" uniqKey="Ishizaki A" first="Azumi" last="Ishizaki">Azumi Ishizaki</name><affiliation><nlm:affiliation>AIDS Clinical Center, International Medical Center of Japan.</nlm:affiliation><wicri:noCountry code="subField">International Medical Center of Japan</wicri:noCountry></affiliation></author><author><name sortKey="Kikuchi, Yoshiki" sort="Kikuchi, Yoshiki" uniqKey="Kikuchi Y" first="Yoshiki" last="Kikuchi">Yoshiki Kikuchi</name></author><author><name sortKey="Hatabu, Toshimitsu" sort="Hatabu, Toshimitsu" uniqKey="Hatabu T" first="Toshimitsu" last="Hatabu">Toshimitsu Hatabu</name></author><author><name sortKey="Kano, Shigeyuki" sort="Kano, Shigeyuki" uniqKey="Kano S" first="Shigeyuki" last="Kano">Shigeyuki Kano</name></author><author><name sortKey="Yasuoka, Akira" sort="Yasuoka, Akira" uniqKey="Yasuoka A" first="Akira" last="Yasuoka">Akira Yasuoka</name></author><author><name sortKey="Oka, Shinichi" sort="Oka, Shinichi" uniqKey="Oka S" first="Shinichi" last="Oka">Shinichi Oka</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2003">2003</date><idno type="RBID">pubmed:12638260</idno><idno type="pmid">12638260</idno><idno type="wicri:Area/PubMed/Corpus">000812</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000812</idno><idno type="wicri:Area/PubMed/Curation">000812</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000812</idno><idno type="wicri:Area/PubMed/Checkpoint">000812</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000812</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[An imported case of falciparum malaria successfully treated with Artemether-Lumefantrine in Japan].</title><author><name sortKey="Ishizaki, Azumi" sort="Ishizaki, Azumi" uniqKey="Ishizaki A" first="Azumi" last="Ishizaki">Azumi Ishizaki</name><affiliation><nlm:affiliation>AIDS Clinical Center, International Medical Center of Japan.</nlm:affiliation><wicri:noCountry code="subField">International Medical Center of Japan</wicri:noCountry></affiliation></author><author><name sortKey="Kikuchi, Yoshiki" sort="Kikuchi, Yoshiki" uniqKey="Kikuchi Y" first="Yoshiki" last="Kikuchi">Yoshiki Kikuchi</name></author><author><name sortKey="Hatabu, Toshimitsu" sort="Hatabu, Toshimitsu" uniqKey="Hatabu T" first="Toshimitsu" last="Hatabu">Toshimitsu Hatabu</name></author><author><name sortKey="Kano, Shigeyuki" sort="Kano, Shigeyuki" uniqKey="Kano S" first="Shigeyuki" last="Kano">Shigeyuki Kano</name></author><author><name sortKey="Yasuoka, Akira" sort="Yasuoka, Akira" uniqKey="Yasuoka A" first="Akira" last="Yasuoka">Akira Yasuoka</name></author><author><name sortKey="Oka, Shinichi" sort="Oka, Shinichi" uniqKey="Oka S" first="Shinichi" last="Oka">Shinichi Oka</name></author></analytic><series><title level="j">Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases</title><idno type="ISSN">0387-5911</idno><imprint><date when="2003" type="published">2003</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Antimalarials (therapeutic use)</term><term>Artemisinins (therapeutic use)</term><term>Female</term><term>Ghana</term><term>Humans</term><term>Malaria, Falciparum (drug therapy)</term><term>Sesquiterpenes (therapeutic use)</term><term>Travel</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Antipaludiques (usage thérapeutique)</term><term>Artémisinines (usage thérapeutique)</term><term>Femelle</term><term>Ghana</term><term>Humains</term><term>Paludisme à Plasmodium falciparum (traitement médicamenteux)</term><term>Sesquiterpènes (usage thérapeutique)</term><term>Voyage</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antimalarials</term><term>Artemisinins</term><term>Sesquiterpenes</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Ghana</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Malaria, Falciparum</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Paludisme à Plasmodium falciparum</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antipaludiques</term><term>Artémisinines</term><term>Sesquiterpènes</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Female</term><term>Humans</term><term>Travel</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Femelle</term><term>Ghana</term><term>Humains</term><term>Voyage</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ghana</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Spread of multi-drug resistant malaria in the endemic areas has made malaria control more difficult. Thus, WHO recommends combination therapy for the treatment of malaria. The aim of combination therapy is to improve efficacy and to reduce the incidence of resistance development to the each component of the combination. Particularly, the combination with artemisinin derivatives shows good outcome in Thailand where high resistance for mefloquine has already been found. We report the first case of falciparum malaria, successfully treated with Artemether-Lumefantrine in Japan. Artemether-Lumefantrine is a newly developed artemisinin-based combination agent for the treatment of uncomplicated multi-drug resistant malaria. This drug has proved highly effective and well tolerated by some clinical trials abroad. This Japanese female case showed a good clinical course without any side effect.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12638260</PMID><DateCreated><Year>2003</Year><Month>03</Month><Day>17</Day></DateCreated><DateCompleted><Year>2003</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2016</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0387-5911</ISSN><JournalIssue CitedMedium="Print"><Volume>77</Volume><Issue>1</Issue><PubDate><Year>2003</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases</Title><ISOAbbreviation>Kansenshogaku Zasshi</ISOAbbreviation></Journal><ArticleTitle>[An imported case of falciparum malaria successfully treated with Artemether-Lumefantrine in Japan].</ArticleTitle><Pagination><MedlinePgn>34-7</MedlinePgn></Pagination><Abstract><AbstractText>Spread of multi-drug resistant malaria in the endemic areas has made malaria control more difficult. Thus, WHO recommends combination therapy for the treatment of malaria. The aim of combination therapy is to improve efficacy and to reduce the incidence of resistance development to the each component of the combination. Particularly, the combination with artemisinin derivatives shows good outcome in Thailand where high resistance for mefloquine has already been found. We report the first case of falciparum malaria, successfully treated with Artemether-Lumefantrine in Japan. Artemether-Lumefantrine is a newly developed artemisinin-based combination agent for the treatment of uncomplicated multi-drug resistant malaria. This drug has proved highly effective and well tolerated by some clinical trials abroad. This Japanese female case showed a good clinical course without any side effect.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ishizaki</LastName><ForeName>Azumi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>AIDS Clinical Center, International Medical Center of Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kikuchi</LastName><ForeName>Yoshiki</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Hatabu</LastName><ForeName>Toshimitsu</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Kano</LastName><ForeName>Shigeyuki</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Yasuoka</LastName><ForeName>Akira</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Oka</LastName><ForeName>Shinichi</ForeName><Initials>S</Initials></Author></AuthorList><Language>jpn</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Kansenshogaku Zasshi</MedlineTA><NlmUniqueID>0236671</NlmUniqueID><ISSNLinking>0387-5911</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037621">Artemisinins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012717">Sesquiterpenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>C7D6T3H22J</RegistryNumber><NameOfSubstance UI="C032942">artemether</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037621" MajorTopicYN="N">Artemisinins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N" Type="Geographic">Ghana</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016778" MajorTopicYN="N">Malaria, Falciparum</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012717" MajorTopicYN="N">Sesquiterpenes</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014195" MajorTopicYN="N">Travel</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>3</Month><Day>18</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>4</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>3</Month><Day>18</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12638260</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Hatabu, Toshimitsu" sort="Hatabu, Toshimitsu" uniqKey="Hatabu T" first="Toshimitsu" last="Hatabu">Toshimitsu Hatabu</name><name sortKey="Ishizaki, Azumi" sort="Ishizaki, Azumi" uniqKey="Ishizaki A" first="Azumi" last="Ishizaki">Azumi Ishizaki</name><name sortKey="Kano, Shigeyuki" sort="Kano, Shigeyuki" uniqKey="Kano S" first="Shigeyuki" last="Kano">Shigeyuki Kano</name><name sortKey="Kikuchi, Yoshiki" sort="Kikuchi, Yoshiki" uniqKey="Kikuchi Y" first="Yoshiki" last="Kikuchi">Yoshiki Kikuchi</name><name sortKey="Oka, Shinichi" sort="Oka, Shinichi" uniqKey="Oka S" first="Shinichi" last="Oka">Shinichi Oka</name><name sortKey="Yasuoka, Akira" sort="Yasuoka, Akira" uniqKey="Yasuoka A" first="Akira" last="Yasuoka">Akira Yasuoka</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000693 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000693 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:12638260
|texte= [An imported case of falciparum malaria successfully treated with Artemether-Lumefantrine in Japan].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:12638260" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |